Rx Medicare

Sixty-four percent of the advisers hired by the Centers for Disease Control and Prevention in 2007 to serve on panels evaluating cervical cancer and flu vaccines had potential conflicts of interest that were unresolved or were not identified by the agency, according to a new report by HHS Inspector General Daniel Levinson, the New York Times reports…

Read More…

Related Posts

• As Influenza Cases Rise In Europe, Experts Urge Uptake Of H1N1 Vaccine
• US H1N1 Swine Flu Vaccine Supply On Track To Hit 10 Million Increase Says CDC Director
• Swine Flu Vaccine Study Says One Shot May Be Enough
• NVIC Says BMJ Review Demonstrates Medical Journal Bias Toward Pharma-Sponsored Influenza Vaccine Studies
• Not Too Late To Get Flu Vaccine, Says Texas Department Of Health
• Baxter Presents Clinical Efficacy Results From Phase III Study Of Seasonal Flu Vaccine
• AmpVacs A Broadly Protective Synthetic Influenza A Vaccine
• Dynavax Selects Clinical Candidate In Universal Flu Vaccine Program
• FDA Recommends H1N1 For Inclusion In Next Year’s Flu Vaccine
• SciClone And Sigma-Tau Announce Additional Positive Results In Clinical Study Examining ZADAXIN’s Ability To Enhance Response To H1N1 Vaccine
• Targeted Prevention Measures Stopped Spread Of H1N1 Flu At Alabama Boys Camp, Doctor Says
• Bharat Biotech Begins Phase I Clinical Trials Of HN-VAC – Its Cell Culture H1N1 Vaccine
• VaxInnate Licenses Recombinant H1N1 Pandemic Swine Flu Vaccine To Biological E.; Vaccine Could Become Available For Use In India This Year
• SciClone And Sigma-Tau Announce Positive Preliminary Results In Clinical Study Examining ZADAXIN’S Ability To Enhance Response To H1N1 Vaccine
• Canada To Bridge Mexico’s H1N1 Flu Vaccine Requirements

Tags: advisory, conflicts, efficacy, experts, panels, says, vaccine

This entry was posted on Monday, December 28th, 2009 at 3:12 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.